Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Expansion of Phenotypically Senescent CD57+ CD8 T Cells Is Associated with Impaired Immunocompetence after Allogeneic Hematopoietic Stem Cell Transplantation

Sarah Morin, Amandine Pradier, Federica Giannotti, Anne-Claire Mamez, Diem-Lan Vu-Cantero, Marta Fabra-Urdiola, Caroline Stephan, Chiara Bernardi, Astrid Melotti, Stavroula Masouridi-Levrat, Eddy Roosnek, Laurent Kaiser, Yves Chalandon, Federico Simonetta

Blood (2021) 138 (Supplement 1): 1807.

https://doi.org/10.1182/blood-2021-153133

Published: 2021

Journal Articles

Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Yves Chalandon, MD, Federico Simonetta, MD PhD, Carole Dantin, MSc, Aikaterini Koutsi, MD, Anne-Claire Mamez, MD, Yan Beauverd, MD, Olga Tsopra, MD, Audrey Simon, MD, Stijn Bex, MD, Caroline Stephan, MD, Juan Felipe Rodriguez Morales, MD, Karolina Polchlopek, MD, Marc Ansari, MD, Yordanka Tirefort, MD, Eddy Roosnek, PhD, Stavroula Masouridi-Levrat, MD

Blood (2016) 128 (22): 2204.

https://doi.org/10.1182/blood.V128.22.2204.2204

Published: 2016

Journal Articles

T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Federico Simonetta, MD PhD, Stavroula Masouridi-Levrat, MD, Yan Beauverd, MD, Olga Tsopra, MD, Yordanka Tirefort, MD, Caroline Stephan, MD, Karolina Polchlopek, MD, Riccardo Favale, MD, Carole Dantin, MSc, Marc Ansari, MD, Eddy Roosnek, PhD, Yves Chalandon

Blood (2015) 126 (23): 3204.

https://doi.org/10.1182/blood.V126.23.3204.3204

Published: 2015

Journal Articles

Decreased Incidence of GvHD after Reduced Intensity Conditioning and a Fixed T-CELL Dose in Hematological Malingnancy Patients

Audrey Simon, Eddy Roosnek, Yordanka Tirefort, Yan Beauverd, Carole Dantin, Olga Tsopra, Jakob R. Passweg, MD, Stavroula Masouridi-Levrat, Yves Chalandon

Blood (2014) 124 (21): 5889.

https://doi.org/10.1182/blood.V124.21.5889.5889

Published: 2014

Journal Articles

Allogeneic Hematopoietic Stem Cells Transplantation for Non-Hodgkin’s Lymphoma. The Swiss Experience 1985-2014

Ekaterina Chigrinova, Sara Fertani, Helen Baldomero, Eddy Roosnek, Gayathri Nair, Johanna Schep, Stavroula Masouridi-Levrat, Urs Schanz, MD, Jakob Passweg, Yves Chalandon

Blood (2014) 124 (21): 1256.

https://doi.org/10.1182/blood.V124.21.1256.1256

Published: 2014

Journal Articles

APRIL Provides Springtime for Antibody-Producing Plasma-Cell Lifetime

Bertrand Huard, PhD, Elodie Belnoue, Thomas Mc Kee, Thomas Matthes, MD, Claire-Anne Siegrist, Eddy Roosnek

Blood (2008) 112 (11): 2568.

https://doi.org/10.1182/blood.V112.11.2568.2568

Published: 2008

Journal Articles

Human NK cells can control CMV infection in the absence of T cells

Taco W. Kuijpers, Paul A. Baars, Carole Dantin, Mirjam van den Burg, Rene A. W. van Lier, Eddy Roosnek

Blood (2008) 112 (3): 914–915.

https://doi.org/10.1182/blood-2008-05-157354

Published: 2008

Journal Articles

Heparan sulfate proteoglycans, Fc receptors, and DC suppression

Eddy Roosnek, Pascal Schneider, Bertrand Huard

Blood (2008) 112 (3): 915–916.

https://doi.org/10.1182/blood-2008-05-156091

Published: 2008

Journal Articles

A Distinct Pattern of Non-HLA Polymorphisms Predicts an Increased Risk for GvHD without Benefit of GvL in HLA Matched Sibling Transplants for Chronic Myeloid Leukemia (CML).

Blood (2006) 108 (11): 54.

https://doi.org/10.1182/blood.V108.11.54.54

Published: 2006

Journal Articles

The EuroChimerism Concept for a Standardized Approach to Chimerism Analysis Following Allogeneic Stem Cell Transplantation.

Thomas Lion, Marcel Tilanus, Hélène Cavé, Mark Lawler, Anna Serra, Andrea Biondi, Jacques van Dongen, Marcos González, Gisela Barbany, Eddy Roosnek, Colin Steward, Peter Bader

Blood (2006) 108 (11): 621.

https://doi.org/10.1182/blood.V108.11.621.621

Published: 2006

Journal Articles

Defibrotide Effectively Prevents Veno-Occlusive Disease of the Liver (VOD) after Allogeneic Stem Cell Transplantation. An Extended Study.

Yves Chalandon, MD, Eddy Roosnek, PhD, Claudine Helg, MD, Frank Verholen, MD, Sabine Knipp, MD, Hulya Ozsahin, MD, Jakob R. Passweg, MD, MS

Blood (2006) 108 (11): 2962.

https://doi.org/10.1182/blood.V108.11.2962.2962

Published: 2006

Journal Articles

Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications

Yves Chalandon, Sylvie Degermann, Jean Villard, Lionel Arlettaz, Laurent Kaiser, Solange Vischer, Steffen Walter, Mirjam H. M. Heemskerk, Rene A. W. van Lier, Claudine Helg, Bernard Chapuis, Eddy Roosnek

Blood (2006) 107 (1): 389–396.

https://doi.org/10.1182/blood-2005-07-2746

Published: 2006

Journal Articles

Impact of Molecular HLA Matching for Allogeneic Stem Cell Transplantation from Unrelated Donors.

Yves Chalandon, MD, Joerg Halter, MD, Tayfun Guengoer, MD, Andre Tichelli, MD, Grazia Nicoloso de Faveri, MD, Bernard Chapuis, MD, Reinhard Seger, MD, Urs Schanz, MD, Alois Gratwohl, MD, Eddy Roosnek, PhD, Jean-Marie Tiercy, PhD, Jakob R. Passweg, MD

Blood (2004) 104 (11): 979.

https://doi.org/10.1182/blood.V104.11.979.979

Published: 2004

Journal Articles

Ex vivo characterization of human CD8 + T subsets with distinct replicative history and partial effector functions

Nathalie Rufer, Alfred Zippelius, Pascal Batard, Mikaël J. Pittet, Isabel Kurth, Patricia Corthesy, Jean-Charles Cerottini, Serge Leyvraz, Eddy Roosnek, Markus Nabholz, Pedro Romero

Blood (2003) 102 (5): 1779–1787.

https://doi.org/10.1182/blood-2003-02-0420

Published: 2003

Journal Articles

Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors

Valérie Bigouret, Till Hoffmann, Lionel Arlettaz, Jean Villard, Marco Colonna, André Ticheli, Alois Gratwohl, Kaveh Samii, Bernard Chapuis, Nathalie Rufer, Eddy Roosnek

Blood (2003) 101 (8): 3198–3204.

https://doi.org/10.1182/blood-2002-08-2408

Published: 2003

Journal Articles

Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

Hermann Einsele, Eddy Roosnek, Nathalie Rufer, Christian Sinzger, Susanne Riegler, Jürgen Löffler, Ulrich Grigoleit, Arnaud Moris, Hans-Georg Rammensee, Lothar Kanz, Annette Kleihauer, Friederike Frank, Gerhard Jahn, Holger Hebart

Blood (2002) 99 (11): 3916–3922.

https://doi.org/10.1182/blood.V99.11.3916

Published: 2002

Journal Articles

Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5 -deficient precursor B-cell clones

Christoph Schaniel, Marie Gottar, Eddy Roosnek, Fritz Melchers, Antonius G. Rolink

Blood (2002) 99 (8): 2760–2766.

https://doi.org/10.1182/blood.V99.8.2760

Published: 2002

Journal Articles

Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential

Nathalie Rufer, Marco Migliaccio, Jennifer Antonchuk, R. Keith Humphries, Eddy Roosnek, Peter M. Lansdorp

Blood (2001) 98 (3): 597–603.

https://doi.org/10.1182/blood.V98.3.597

Published: 2001

Journal Articles

Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation

Nathalie Rufer, Tim H. Brümmendorf, Bernard Chapuis, Claudine Helg, Peter M. Lansdorp, Eddy Roosnek

Blood (2001) 97 (2): 575–577.

https://doi.org/10.1182/blood.V97.2.575

Published: 2001

Journal Articles

Recovery of immune reactivity after T-cell–depleted bone marrow transplantation depends on thymic activity

Etienne Roux, Florence Dumont-Girard, Michel Starobinski, Claire-Anne Siegrist, Claudine Helg, Bernard Chapuis, Eddy Roosnek

Blood (2000) 96 (6): 2299–2303.

https://doi.org/10.1182/blood.V96.6.2299

Published: 2000

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Expansion of Phenotypically Senescent CD57+ CD8 T Cells Is Associated with Impaired Immunocompetence after Allogeneic Hematopoietic Stem Cell Transplantation

Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Decreased Incidence of GvHD after Reduced Intensity Conditioning and a Fixed T-CELL Dose in Hematological Malingnancy Patients

Allogeneic Hematopoietic Stem Cells Transplantation for Non-Hodgkin’s Lymphoma. The Swiss Experience 1985-2014

APRIL Provides Springtime for Antibody-Producing Plasma-Cell Lifetime

Human NK cells can control CMV infection in the absence of T cells

Heparan sulfate proteoglycans, Fc receptors, and DC suppression

A Distinct Pattern of Non-HLA Polymorphisms Predicts an Increased Risk for GvHD without Benefit of GvL in HLA Matched Sibling Transplants for Chronic Myeloid Leukemia (CML).

The EuroChimerism Concept for a Standardized Approach to Chimerism Analysis Following Allogeneic Stem Cell Transplantation.

Defibrotide Effectively Prevents Veno-Occlusive Disease of the Liver (VOD) after Allogeneic Stem Cell Transplantation. An Extended Study.

Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications

Impact of Molecular HLA Matching for Allogeneic Stem Cell Transplantation from Unrelated Donors.

Ex vivo characterization of human CD8 + T subsets with distinct replicative history and partial effector functions

Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors

Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5 -deficient precursor B-cell clones

Transfer of the human telomerase reverse transcriptase (TERT) gene into T lymphocytes results in extension of replicative potential

Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation

Recovery of immune reactivity after T-cell–depleted bone marrow transplantation depends on thymic activity

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only